References
Essary LR, Wick MR. Cutaneous calciphylaxis. An underrecognized clinicopathologic entity.Am J Clin Pathol 2000; 113: 280–7.
Budisaljevic MN, Cheek C, Ploth DW. Calciphylaxis in chronic renal failure.J Am Soc Nephrol 1996; 7: 978–82.
Llach F. Calcific uremic arteriolopathy (calciphylaxis): an evolving entity?Am J Kidney Dis 1998; 32: 514–8.
Mazhar AR, Johnson RJ, Gillen D, et al. Risk factors and mortality associated with calciphylaxis in end-stage renal disease.Kidney Int 2001; 60: 324–32.
Davies MR, Hruska KA. Pathophysiological mechanisms of vascular calcification in end-stage renal disease.Kidney Int 2001; 60: 472–9.
Giachelli CM, Speer MY, Li X, Rajachar RM, Yang H. Regulation of vascular calcification. Roles of phosphate and osteopontin.Circ Res 2005; 96: 717–22.
Ahmed S, O’Neill KD, Hood AF, Evan AP, Moe SM. Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells.Am J Kidney Dis 2001; 37: 1267–76.
Schäfer C, Heiss A, Schwarz A, et al. The serum protein α2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification.J Clin Invest 2003; 112: 357–66.
Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a crosssectional study.Lancet 2003;361:827–33.
Stenvinkel P, Wang K, Qureshi AR, et al. Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin.Kidney Int 2005; 67: 2383–92.
Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int 2002; 61: 2210–17.
Wilmer WA, Magro CM. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment.Semin Dial 2002; 15: 172–86.
Llach F. The evolving pattern of calciphylaxis: therapeutic considerations.Nephrol Dial Transplant 2001; 16: 448–51.
Monney P, Nguyen QV, Perroud H, Descombes E. Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure.Nephrol Dial Transplant 2004; 19: 2130–2.
Green JA, Green CR, Minott SD. Calciphylaxis treated with neurolytic lumbar sympathetic block: case report and review of the literature.Reg Anesth Pain Med 2000; 25: 310–2.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Garini, G., Galletti, E., Ricci, R. et al. Calciphylaxis: evolving concepts. Int Emergency Med 1, 320–322 (2006). https://doi.org/10.1007/BF02934772
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02934772